Literature DB >> 9149902

Differential expression of MEK1 and MEK2 during mouse development.

A Alessandrini1, B K Brott, R L Erikson.   

Abstract

Map/Erk kinase 1 (MEK1) and MEK2 activate the Erk/ MAP kinases and have been implicated in cell growth and differentiation. To investigate the role of MEKs during mouse development, we have examined their expression and activity in various murine tissues during embryonic development and in the adult mouse. MEK2 RNA message is expressed at high levels in all embryonic tissues examined, including all neural tissues, and liver. This can be observed by in situ hybridization of tissue sections of 14.5-day-old mouse embryos, as well as by Northern blot analyses. MEK1, on the other hand, is expressed at very low levels in most embryonic murine tissue but can be detected in developing skeletal muscle. It is expressed at higher levels in adult tissue, particularly in brain, where it is expressed at high levels. Western blot analyses of MEK1 and MEK2 in 14.5-day-old embryonic and adult mouse tissue confirm the RNA analysis. Levels of MEK1 kinase activity are particularly high in adult brain tissues as well. These findings suggest that MEK2 may be the primary Erk/MAP kinase activator during development and that MEK1 may play a role in the proliferative or mitogenic response in adult mouse tissues. This study also raises the possibility that MEK1 and MEK2 might not have redundant functions in cells but may possess unique specificity in their interactions with upstream activators or downstream targets.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9149902

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  7 in total

1.  Pathogenetics of the RASopathies.

Authors:  William E Tidyman; Katherine A Rauen
Journal:  Hum Mol Genet       Date:  2016-07-12       Impact factor: 6.150

Review 2.  Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development.

Authors:  Eva Chung; Motonari Kondo
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

3.  Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival.

Authors:  Ya-Li Zheng; Bing-Sheng Li; Jyotshna Kanungo; Sashi Kesavapany; Niranjana Amin; Philip Grant; Harish C Pant
Journal:  Mol Biol Cell       Date:  2006-11-15       Impact factor: 4.138

4.  NF-kappa B DNA-binding activity in embryos responding to a teratogen, cyclophosphamide.

Authors:  Arkady Torchinsky; Lucy Lishanski; Orit Wolstein; Jeanne Shepshelovich; Hasida Orenstein; Shoshana Savion; Zeev Zaslavsky; Howard Carp; Alexander Brill; Rivka Dikstein; Vladimir Toder; Amos Fein
Journal:  BMC Dev Biol       Date:  2002-02-05       Impact factor: 1.978

5.  Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway.

Authors:  Li-Xin Ren; Jin-Chun Qi; An-Ning Zhao; Bei Shi; Hong Zhang; Dan-Dan Wang; Zhan Yang
Journal:  Cancer Cell Int       Date:  2021-06-28       Impact factor: 5.722

Review 6.  ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?

Authors:  Roser Buscà; Jacques Pouysségur; Philippe Lenormand
Journal:  Front Cell Dev Biol       Date:  2016-06-08

7.  Helicobacter pylori-Induced HB-EGF Upregulates Gastrin Expression via the EGF Receptor, C-Raf, Mek1, and Erk2 in the MAPK Pathway.

Authors:  Niluka Gunawardhana; Sungil Jang; Yun Hui Choi; Youngmin A Hong; Yeong-Eui Jeon; Aeryun Kim; Hanfu Su; Ji-Hye Kim; Yun-Jung Yoo; D Scott Merrell; Jinmoon Kim; Jeong-Heon Cha
Journal:  Front Cell Infect Microbiol       Date:  2018-01-15       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.